These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24382103)

  • 1. Monthly haemostatic factor variability in women and men.
    Hill AM; Stewart PW; Fung MK; Kris-Etherton PM; Ginsberg HN; Tracy RP; Pearson TA; Lefevre M; Reed RG; Elmer PJ; Holleran S; Ershow AG;
    Eur J Clin Invest; 2014; 44(3):309-18. PubMed ID: 24382103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators.
    Reed RG; Kris-Etherton P; Stewart PW; Pearson TA
    Metabolism; 2000 Sep; 49(9):1101-5. PubMed ID: 11016887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic variability of hemostatic and fibrinolytic factors in young women.
    Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation.
    Andersson O; Blombäck M; Bremme K; Wramsby H
    Thromb Haemost; 1997 May; 77(5):901-4. PubMed ID: 9184400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Intakes of Vitamin B-2 (Riboflavin), Vitamin B-6, and Vitamin B-12 and Ovarian Cycle Function among Premenopausal Women.
    Kim K; Mills JL; Michels KA; Chaljub EN; Wactawski-Wende J; Plowden TC; Mumford SL
    J Acad Nutr Diet; 2020 May; 120(5):885-892. PubMed ID: 31879178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
    Gebara OC; Mittleman MA; Sutherland P; Lipinska I; Matheney T; Xu P; Welty FK; Wilson PW; Levy D; Muller JE
    Circulation; 1995 Apr; 91(7):1952-8. PubMed ID: 7895352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.
    Kris-Etherton PM; Stewart PW; Ginsberg HN; Tracy RP; Lefevre M; Elmer PJ; Berglund L; Ershow AG; Pearson TA; Ramakrishnan R; Holleran SF; Dennis BH; Champagne CM; Karmally W;
    J Nutr; 2020 Aug; 150(8):2089-2100. PubMed ID: 32492148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
    Lindoff C; Peterson F; Lecander I; Martinsson G; Astedt B
    Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
    Borgfeldt C; Li C; Samsioe G
    Climacteric; 2004 Mar; 7(1):78-85. PubMed ID: 15259286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.
    Svendsen OL; Hassager C; Christiansen C; Nielsen JD; Winther K
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):381-5. PubMed ID: 8630663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of menstrual cycle and menopause on internal carotid artery shear-mediated dilation in women.
    Iwamoto E; Sakamoto R; Tsuchida W; Yamazaki K; Kamoda T; Neki T; Katayose M; Casey DP
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H679-H689. PubMed ID: 33306444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemostatic variables during normal menstrual cycle. A systematic review.
    Knol HM; Kemperman RF; Kluin-Nelemans HC; Mulder AB; Meijer K
    Thromb Haemost; 2012 Jan; 107(1):22-9. PubMed ID: 22159564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.
    Niskanen L; Schwab US; Sarkkinen ES; Krusius T; Vahtera E; Uusitupa MI
    Metabolism; 1997 Jun; 46(6):666-72. PubMed ID: 9186303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol intake, reproductive hormones, and menstrual cycle function: a prospective cohort study.
    Schliep KC; Zarek SM; Schisterman EF; Wactawski-Wende J; Trevisan M; Sjaarda LA; Perkins NJ; Mumford SL
    Am J Clin Nutr; 2015 Oct; 102(4):933-42. PubMed ID: 26289438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of physical activity across the menstrual cycle on reproductive function.
    Ahrens KA; Vladutiu CJ; Mumford SL; Schliep KC; Perkins NJ; Wactawski-Wende J; Schisterman EF
    Ann Epidemiol; 2014 Feb; 24(2):127-34. PubMed ID: 24345590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.
    De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R
    Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle.
    Chaireti R; Gustafsson KM; Byström B; Bremme K; Lindahl TL
    Hum Reprod; 2013 Jul; 28(7):1846-52. PubMed ID: 23592222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.